Orion will remain as the owner of pharmaceutical manufacturing plant in Kuopio, Finland
ORION CORPORATION Â Â Â Â Â Â Â Â Â PRESS RELEASE Â Â Â Â Â Â Â Â Â Â Â Â Â 17 AUGUST 2021 at 8.00. a.m. EEST Orion will…
ORION CORPORATION Â Â Â Â Â Â Â Â Â PRESS RELEASE Â Â Â Â Â Â Â Â Â Â Â Â Â 17 AUGUST 2021 at 8.00. a.m. EEST Orion will…
MELBOURNE, Australia and ADELAIDE, Australia, Aug. 17, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX:…
MELBOURNE, Australia and LONDON , Aug. 17, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX:…
Continued strength in unit demand across key product lines Rupall unit demand growth of 44%…
PORTLAND, Ore., Aug. 16, 2021 (GLOBE NEWSWIRE) — Chalice Brands Ltd., formerly Golden Leaf Holdings…
Secured funding of approximately $138 million through merger and private placement investment in public equity…
EMERYVILLE, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) — Zogenix (NASDAQ: ZGNX) today announced that the compensation…
Corvus Partner Angel Pharmaceuticals Plans to Initiate Trial by Year-end 2021 BURLINGAME, Calif., Aug. 16,…
Lowell Reports 37% sequential growth in revenue driven by large cultivation yields advances and strong…
Groundbreaking Progress in Clinical Trial and Drug Discovery Programs Enhanced Technology Offering with Mindleap 2.0,…
SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”)…
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
PALATINE, Ill., Aug. 16, 2021 (GLOBE NEWSWIRE) — Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative…
Added Additional Treatment Arm and Provided Enrollment Update for Ongoing ELX-02 Phase 2 Clinical Trials…
Announced first patient dosed in Phase 1 trial evaluating KIN-2787 in patients with BRAF mutation-positive solid…
Acumen’s investigational drug, ACU193, is the first humanized monoclonal antibody discovered and developed to selectively…
Sale of legacy business to Alora Pharmaceuticals, LLC expected to close in third quarter 2021…
Top-line data from ongoing Phase 1 proof of concept clinical trial of TERN-501 expected in…
DEER PARK, Ill., Aug. 16, 2021 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an…
– Initiated open label extension for LIFT-AD and ACT-AD trials of ATH-1017 allowing for an…